local_hospital

Jessa Hospital

Address
Stadsomvaart 11, 3500 Hasselt, Belgium, Hasselt, Belgium

Jessa Hospital - Cardiovascular & Neurovascular Research Center

Jessa Hospital is a distinguished clinical research institution specializing in complex cardiovascular and cerebrovascular conditions. The center demonstrates particular expertise in managing high-risk patient populations requiring delicate therapeutic balance, including those with histories of serious bleeding complications and acute cardiac emergencies.

  • Anticoagulation therapy in atrial fibrillation patients with prior intracranial hemorrhage
  • High-dose corticosteroid interventions for severe acute myocarditis
  • Stroke prevention strategies in complex bleeding-risk populations

The research center focuses on critical decision-making scenarios in cardiovascular medicine, evaluating innovative treatment approaches for conditions such as fulminant acute myocarditis and optimizing anticoagulation strategies in patients with atrial fibrillation who have experienced intracranial bleeding. Their investigations address challenging clinical dilemmas where standard therapeutic approaches may carry significant risks, seeking to establish evidence-based protocols that balance efficacy with safety in vulnerable patient populations.

Site Overview

assignment
2
connected trials
corporate_fare
3
sponsors
science
3
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
3
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 307 other sites in Belgium

description
Trial volume
2
Outperforms 60% of sites
public
Therapeutic diversity
1areas
Outperforms 1% of sites
groups
Sponsor diversity
3sponsors
Outperforms 71% of sites

Therapeutic Area Benchmark — Belgium

Select a therapeutic area to compare against other sites in Belgium.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Belgium

Market Share

Country: Belgium

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Jessa Hospital

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Edoxaban Versus Nonanticoagulant Therapy in High-Risk Atrial Fibrillation Patients with Prior Intracranial HemorrhageHamilton Health Sciences Corporation, PHRI Population Health Research Institute InternationalPhase IIINot RecruitingDec 2024Jul 2026

IMP list

lock Showing 1 of 3 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Edoxaban1Unknown2024-12-092024-12-09

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.